Analyst firms · H.C. Wainwright · ANAB

H.C. Wainwright ANAB price target and rating history

AnaptysBio Inc. (ANAB) · Health Care

H.C. Wainwright rates AnaptysBio Inc. (ANAB) Buy with a $95 price target, as of its latest action on Jun 10, 2026. It has published 6 rating actions on ANAB since March 2022, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$95
Median target, all firms
Too few
Actions on ANAB
6

H.C. Wainwright price target on ANAB

$95$57$192023202420252026
H.C. Wainwright price target on ANAB, each point a stated target, March 2022 to June 2026.

Every H.C. Wainwright rating on ANAB

How other firms rate ANAB

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightBuy$95Jun 10, 2026
UBSBuy$70Jan 7, 2026

Questions about H.C. Wainwright and ANAB

What is H.C. Wainwright's price target for ANAB?
H.C. Wainwright's latest stated price target for AnaptysBio Inc. (ANAB) is $95, from its action on Jun 10, 2026.
What is H.C. Wainwright's rating on ANAB?
H.C. Wainwright rates ANAB Buy, a bullish rating, as of Jun 10, 2026.
When did H.C. Wainwright last change its view on ANAB?
On Jun 10, 2026, H.C. Wainwright resumes coverage at Buy, price target $95.

All H.C. Wainwright ratingsANAB news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.